Topic Archives: Hepatitis C

Comments

  • $EBIO just took off wow ZKSS come home! PLEASE! $ENTA np - The Chart of the Day belongs to Enanta Pharmaceutica...

  • Hepatitis I have known at least 10 individuals who contracted hepatitis. Of this group, two died, both in their 40’...

  • I 'd say Hepatitis C, as it is a chronic form of hepatitis and has a high prevalence in specific groups of people that I...

  • $Hepatitis D. Hepatitis D virus (HDV) is an RNA virus that was discovered in 1977 and is structurally unrelated to t...

  • Fine with me. Might be good to put it in a box on the face page in the new version. For this week: Which kind of virus...

  • $LiverFibrosis. $INLF3 "World-First Discovery Of Protein That Causes Liver Disease Brings Hope For New Treatments" ...

  • How is hepatitis C transmitted? http://www.medicalnewstoday.com/articles/318888.php AASLD 2017 In Washington - 20 to...

  • FDA approves Mavyret for Hepatitis C https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm570038.htm...

  • Draft Order on Drug Prices Proposes Easing Regulations https://www.nytimes.com/2017/06/20/health/draft-order-on-drug-pr...

  • $RGLS: There is a urgent need amongst the medical franternity for SCY-078, deadly superbug Candida auris treatment, whil...

  • $HCV $GILD, $CELG Unlike its viral cousins hepatitis A and B, hepatitis C virus (HCV) has eluded the development of a...

  • Wide Use of New HCV (Hepatitis C) Drugs Prevents New Cases: http://www.medpagetoday.com/MeetingCoverage/CROI/63242 Di...

  • Interesting article - tourist's travel to Egypt for Solvadi 6K Hepatitis C Tx. Could someone with a Stat membership ple...

  • $GILD $RGLS W #HCV #HCC #TumorEnvironment *Hepatocellular Carcinoma Decreases the Chance of Successful Hepatitis C Vi...

  • $ACHN: Ladenburg Thalmann Dossier released today. Author: Christopher S. James, M.D. https://ladenburg.bluematrix.com/...

  • $RGLS On Wednesday the NYT published, "Are New Drugs for Hepatitis C Safe? A Report Raises Concerns: https://www.nyt...

  • Dear RGLS/Prospective investors, I hope this can appease your anxiety, over the heavy-pall smokescreen currently hangs ...

  • Related to this, an interesting proposal out of Forbes today advocating for the U.S government to buy Gilead to the tune...

  • A phase 1b of RG-101 was published in The Lancet recently: "Safety, tolerability, and antiviral effect of RG-101 in p...

  • This abstract more than likely moving RGLS of late. Background and aims: MicroRNA (miR)-122 is the most abundant mi...

  • Trouble in G-land....from WSJ last night armaceutical company’s overall profit down to $3.33 billion from $4.6 bill...

  • $GILD Very interesting... Here we describe a patient with advanced follicular lymphoma and concurrent hepatitis C vi...

  • Interesting clip from NYT: Your Surgeon Is Probably a Republican, Your Psychiatrist Probably a Democrat Margot Sange...

  • FDA Drug Safety Communication: FDA warns about the risk of hepatitis B reactivating in some patients treated with direct...

  • $GILD $GSK #HIV - Barrons just published an article on this subject, quoting a Piper Jaffray's analyst who mildly refute...

  • Re: pharmacy benefits managers As reported by Fierce Pharma, for the third year in a row, Express Scripts unveiled a...

  • In case you didn't notice, GILD ran up a little bit into earnings, then disappointed on forward guidance when they repor...

  • Gilead is on the cusp of a public relations debacle perhaps as big as Enron though it's anything but fishy finances so i...

  • RGLS I would appreciate vey much if somebody could give us an idea how long it will take to remove the clinical hold re...

  • Full text article from The Lancet: http://www.natap.org/2016/HCV/PIIS01406736163057972.pdf Virus hepatitis (C and B) ...

  • Doc, just read the news that FDS places Regulus's hepatitis C treatment on hold. Would appreciate if you can share your ...

  • $RGLS Regulus Therapeutics (NASDAQ:RGLS) inks a loan and security agreement with Oxford Finance LLC for up to $30M i...

  • GILD (not long) http://blogs.barrons.com/stockstowatchtoday/2016/06/17/gilead-sciences-a-strong-uptick-in-new-hepatitis-...

  • Dr. KSS: REACHMD is offering CME on co-management of Hepatitis C treatment between primary care providers and specialist...

  • Just this past week, a lady in our church lost a brother in his 40's due to undiagnosed Hepatitis C which turned into ca...

  • An estimated 3.9 million people are infected with hepatitis C in the United States. “For everyone born between 1945 a...

  • Long RGLS and Dr KSS. I came across a very good article in today's Pittsburgh Post-Gazette (5/5/16) Hepatitis C causing ...

  • Re $RGLS Listened the conference call over the weekend, and came away quite bullish over the medium term. Little disapp...

  • $RGLS That Dr KSS is an advisor to RGLS gives me confidence. The Fool article concludes with this: "Overall, the sell-...

  • $GILD - RE Merck's Zepatier Gilead Sciences: ‘Another Pretender to Hepatitis C Throne Seems to Be Suffering the Ab...

  • CHC is chronic hepatitis C. It's a terrible term and abbreviation, as HCV is rarely acute and virtually always becomes c...

  • Hepatology has long operated under the idea that the heyday of HCV was the 1960s and 1970s, That it was practices of peo...

  • Gilead: ''A federal jury on Thursday ordered Gilead Sciences Inc (GILD.O) to pay Merck & Co (MRK.N) $200 million in dama...

  • Among people with HCV who are seropositive for HBV, occasional concern has been repeatedly voiced that the new oral agen...

  • $GILD Why One Analyst Sees Gilead Worth 66% More Argus puts a Buy on GILD with a $150 target. "In February and...

  • SYDNEY, Feb. 26, 2016 /PRNewswire/ -- Benitec Biopharma (ASX: BLT; NASDAQ: BNTC; NASDAQ: BNTCW) announced today that it ...

  • Benitec’s Board made the decision to discontinue the hepatitis C program following a review of the co...

  • $RGLS Did anyone else see this or have thoughts after reading? No explanation why ALNY took this action and trying t...

  • $GILD Longtime Gilead Sciences CEO John Martin is stepping down and is being replaced by John Milligan, the Foster City...

  • $CNAT, $GNFTF Doc you wrote in http://www.stockgumshoe.com/2014/12/microblog-dawn-of-the-planet-of-the-tloglodytes/ ...

  • re: $GILD Fascinating NY Times Article today on overseas pricing of hepatitis C medication (sofosbuvir) and the huge i...

  • Serious coin to be made from this new test: A Novel HCV Antigen Test System for One-step Screening and Diagnosing Vir...

  • Ward/Herman editorial appearing yesterday in NEJM. Regards HCV drug costs; bottom line, they're worth it. Simple, Eff...

  • Enzo Biochem (ENZ) new 52wH after New York cleared Hepatitis C Test. Could be one for Dr. KSS?...

  • "I am not there to judge them, I am there to care for them, to care for them well" That reminds me of a comment on F...

  • $GILD Gilead's Sovaldi tied to slow heartbeat in hepatitis C patients By Michelle Fay Cortez Bloomberg News PO...

  • Study suggests unprecedented 3-week hepatitis C cure http://news.sciencemag.org/health/2015/10/study-suggests-unprecede...

  • $GILD- Gilead Sciences: Its Hepatitis-C Treatments Keep Getting Better http://blogs.barrons.com/stockstowatchtoday/20...

  • Some AbbVie news: FDA Drug Safety Communication: FDA warns of serious liver injury risk with hepatitis C treatments Viek...

  • BMY- Interesting about different HCV genotypes as well: NICE Recommends Daklinza (daclatasvir) for Treatment of Certai...

  • $RGLS Update Regulus to Present Updated Data Supporting RG-101 as Novel microRNA Therapeutic for the Treatment of H...

  • New paper out of the CDC "confirming" what smart hepatologists have known for 15 years. There are fools out there who ar...

  • Thoughts doctor, an HCV vaccine, Cambridge Biotech a legitimate contender? (Ap0logies if this co. has already been d...

  • Jabber: here it is ential acquisitions get cheaper, Gilead Sciences might be a beneficiary of recent market turmoi...

  • Thanks for the heads up, Mr. Paglee. First we have Socialist Bernie Sanders urging the VA to scuttle GILD's hepatitis C...

  • THE ANTIDOTE: INSIDE THE WORLD OF NEW PHARMA by Barry Werth (2014) In 'The Antidote,' Barry Werth picks up the stor...

  • $AGN - gotta like this guy... Allergan CEO says better to leave discoveries to others By Ransdell Pierson Aug 6 A...

  • An impassioned post from Jules Levin, HCV treatment advocate: Compare Prices - HCV Drug Pricing vs New Cholesterol Dr...

  • Dr.KSS, thanks for posting this story from today's WSJ. It has a bit more about the Mayo Clinic editorial than is prin...

  • GILD's HEP C scripts latest data. Gilead Sciences: Does Anyone Care About Hep-C Anymore? By Ben Leviso...

  • New SEC filing by Benitec. Within it it states "We are developing a ddRNAi-based therapeutic, TT-034, for the treatmen...

  • For those who cannot open link on Baron's article. Peter Kolchinsky was 4 years old when he arrived in Milwaukee with...

  • WSJ today: Rural U.S. Struggles to Combat IV Drug Abuse Hepatitis C and HIV outbreaks test public-health resources i...

  • Nice article on Hepatitis C. http://www.medscape.com/viewarticle/846347?src=wnl_edit_specol Cheers,Glenn...

  • $ESPR & $GILD Cost-Effectiveness and Affordability of New Medicines (3) The cost-effectiveness of treatments for chr...

  • GILD Drug developer GlobeImmune Inc said its experimental hepatitis B drug did not reduce infection in patients after 2...

  • In marketing terms, it looks so far like the "thunderclap" of trying to get Hepatitis C Testing Day trending on Twitter ...

  • ACHN-Achillion Enters Into Worldwide Collaboration For Hepatitis C With Janssen4:05 pm ET Best2ALL!-Benjamin...

  • Well, the "announcement" did happen -- just doesn't mean nearly as much, in the immediate term, for any one stock as was...

  • hay read most of the comments. all very to the point and funny, you always know when you show interest in their speal it...

  • $GILD Here is a short excerpt from an article in today’s Science Dailey: “While a new generation of safer, more ef...

  • Kenny G, Thanks for the links you posted. You’re not the only one still in Benitec. Let me commiserate -- it’s no...

  • A different perspective of $ACHN. Analyst Issues 5 Potential Biotech Buyout Candidates By Lee Jackson May 14, 2015 9:...

  • The VA’s Hepatitis C Problem Newsweek By Gerard Flynn 5/9/15 at 11:00 AM http://www.newsweek.com/vas-hepatitis-c-p...

  • Don’t Buy Gilead’s Headline Gilead Sciences (GILD – NASDAQ) By Bottarelli Research Published Friday, May 01, 20...

  • Tackling HBV in NYC, where 1/12 Asians has it. NY City Council Moves to Require Hepatitis Reporting Summary of Bil...

  • Re: Hepatitis C Data revealed Thursday at EASL (International Liver Congress) highlights the adverse impact of delayin...

  • Was surprised this hadn't been shared before but looks good for us $GILD longs. "Gilead Announces Data for Investigat...

  • I sure wish Dr. KSS were around, I'm sure he would give me a proper "drop and give me 20" for even posting this, howe...

  • ACHN-At EASL : Achillion Pharmaceuticals, Inc. (Nasdaq:ACHN) today announced that it will present three posters, includi...

  • Kenny/Kris, Did you guys get this letter/ Dear joe, I am pleased to share the latest report from Lodge Partners i...

  • GILD-M&A soon maybe? Gilead More Open to Deals -- Market Talk 4/3/15 4:46 PM ET (Dow Jones) -- Gilead (GILD) Chief Oper...

  • $GILD The FDA accepts for review Bristol-Myers Squibb's (BMY +1.6%) resubmitted New Drug Application (NDA) for daclatas...

  • Motley Fool Morning Headline: "Could This Be The Biggest Advance in Hepatitis C since Gilead Sciences' Sovaldi?" htt...

  • RE:GILD – good news from Barron’s. Long GILD. RBC’s Michael Yee and team think AbbVie’s (ABBV) update on its he...

  • Could this be part of the reason for Gild going sideways. This seems goofy. Widespread hepatitis C screening - do ben...

  • GILD expands Hepatitis C Generic Licensing Agreements. http://finance.yahoo.com/news/gilead-expands-hepatitis-c-generic...

  • Here's the Barrons comment on GILD--- Gilead Sciences: Gilead Sciences won us over after last week’s 14% plunge in i...

  • It is truly appalling that benefits managers (such as Express Scripts) can arbitrarily veto the treating physician’s p...

  • We use cookies on this site to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies.

    More Info